ImmunologybioRxivPreprint
ELIMINATION OF EGFR-OVEREXPRESSING CANCER CELLS BY CD32 CHIMERIC RECEPTOR T CELLS IN COMBINATION WITH CETUXIMAB OR PANITUMUMAB
Sara Caratelli, Roberto Arriga, Tommaso Sconocchia…·Giuseppe Sconocchia
This study shows CD32131R-CR T cells can eliminate EGFR-overexpressing cancer cells when combined with cetuximab or panitumumab, outperforming CD16158F-CR T cells.
DOI 10.1101/581017